Ground Fluor Pharmaceuticals develops new imaging agents for use in diagnosis and management of disease, and to help other companies.
Ground Fluor Pharmaceuticals developed new chemistry technology which transforms complicated and costly fluorine syntheses into simpler, more efficient processes. Using technology developed at the University of Nebraska and the Massachusetts General Hospital and funded by the National Science Foundation and Cedarville Investments, Ltd., GFP has developed and patented processes and intermediate chemicals for the efficient, cost-effective production of PET imaging agents.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 3, 2014 | Grant | $1.34M | 1 | National Science Foundation | — | Detail |
Jun 14, 2012 | Grant | $180K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |